Where is Shared Decision Making in Relapsed/Refractory Multiple Myeloma? A Qualitative Study

被引：0
|
作者：
Foulon, Veerle [1 ]
Sillis, Laure [1 ]
Panis, Laura Int [2 ]
Van Hecke, Ann [3 ]
Damiaens, Amber [1 ]
机构：
[1] Katholieke Univ Leuven, Leuven, Belgium
[2] Sciensano, Brussels, Belgium
[3] Univ Ghent, Ghent, Belgium
来源：
PATIENT EDUCATION AND COUNSELING | 2023年 / 109卷
关键词：
D O I：
10.1016/j.pec.2022.10.031
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
O.4.2
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [31] Carfilzomib for relapsed and refractory multiple myeloma
    Groen, K.
    van de Donk, N. W. C. J.
    Stege, C. A. M.
    Zweegman, S.
    Nijhof, I. S.
    [J]. CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 2663 - 2675
  • [32] Treatment of relapsed and refractory multiple myeloma
    Lee, Ji Hyun
    Kim, Sung-Hyun
    [J]. BLOOD RESEARCH, 2020, 55 : 43 - 53
  • [33] Phase Ib Study of Panobinostat and Bortezomib in Relapsed or Relapsed and Refractory Multiple Myeloma
    San-Miguel, Jesus F.
    Richardson, Paul G.
    Guenther, Andreas
    Sezer, Orhan
    Siegel, David
    Blade, Joan
    LeBlanc, Richard
    Sutherland, Heather
    Sopala, Monika
    Mishra, Kaushal K.
    Mu, Song
    Bourquelot, Priscille M.
    Victoria Mateos, Maria
    Anderson, Kenneth C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (29) : 3696 - +
  • [34] Therapy of relapsed and relapsed-refractory Multiple Myeloma
    Driessen, C.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 8 - 8
  • [35] A phase I study of thymoglobulin for relapsed or refractory multiple myeloma
    Keller, Jesse
    Fiala, Mark A.
    Dipersio, John
    Stockerl-Goldstein, Keith
    Vij, Ravi
    Heldermon, Coy D.
    [J]. LEUKEMIA & LYMPHOMA, 2016, 57 (02) : 453 - 455
  • [36] The Role of Demographic and Social Factors on Decision Making in Patients with Relapsed and Refractory Multiple Myeloma Treated By Ixazomib, Lenalidomide and Dexamethasone
    Minarik, Jiri
    Jungova, Alexandra
    Straub, Jan
    Gregora, Evzen
    Bryknarova, Jana
    Nemcova, Blanka
    Hajek, Roman
    [J]. BLOOD, 2019, 134
  • [37] Elotuzumab: A Review in Relapsed and/or Refractory Multiple Myeloma
    Lamb, Yvette N.
    [J]. DRUGS, 2018, 78 (14) : 1481 - 1488
  • [38] Ixazomib: A Review in Relapsed and/or Refractory Multiple Myeloma
    Al-Salama, Zaina T.
    Garnock-Jones, Karly P.
    Scott, Lesley J.
    [J]. TARGETED ONCOLOGY, 2017, 12 (04) : 535 - 542
  • [39] Lenalidomide for the treatment of relapsed or refractory multiple myeloma
    Weber, D. M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 22 - 24
  • [40] Spotlight on Lenalidomide in Relapsed or Refractory Multiple Myeloma
    Lesley J. Scott
    Katherine A. Lyseng-Williamson
    [J]. BioDrugs, 2011, 25 : 333 - 337
12345